JD Health International, Inc. Financials

Market Capitalization €11.89 Billion as of Jan. 1, 2025

Valuations Metrics as of Jan. 25, 2025

Trailing PE	33.09
Forward PE
Price to Sales TTM	€0.22
Price to Book MRQ	€0.22
Enterprise to Revenue	-0.66
Enterprise to EBITDA	-38.27

Financial Reports as of Dec. 31, 2023

Financials

Fiscal Year Ends	2023-12-31
Most Recent Quarter	2023-12-31
Profit Margin	4.78%
Operating Margin	3.65%
Return on Assets TTM	0.77%
Return on Equity TTM	5.19%

Income Statement

Revenue TTM	€7,226,221,080
Revenue per Share TTM	€17.48
Quarterly Revenue Growth	4.60%
Gross Profit TTM	€1,631,240,778
EBITDA	€3,000,150,000
Net Income to Common TTM	€345,408,962
Diluted EPS TTM	€0.11
Quarterly Earnings Growth YoY	30.50%

Balance Sheet

Total Cash MRQ	€6,323,175,514
Total Cash per Share MRQ	€15.26
Total Debt MRQ	€
Total Debt to Equity MRQ	0.42
Current Ratio MRQ	3.74
Book Value per Share MRQ	€16.60

Cash Flow

Operating Cash Flow TTM	€853,321,153
Levered Free Cash Flow TTM	€517,193,715

8ZN Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	3,198,569,984
Float Shares	1,006,918,525
Avg 10 Volume	1,207
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	67.76%
% Held by Institutions	12.43%

Stock Price Summary

Beta	1.00
Fifty Two Week Low	€2.28
Fifty Two Week High	€4.14
Fifty Two Week Change	16.06%
Day 50 MA	€3.47
Day 200 MA	€3.09

Dividends and Splits

Forward Annual Dividend Rate	€
Forward Annual Dividend Yield	%
Trailing Annual Dividend Rate	€0.00
Trailing Annual Dividend Yield	0.00%
Payout Ratio	0.00%
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date